Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Advocacy (policy advocacy, lobbying)
Neurology/Parkinson's Disease (1)
Academic Medical Center/Hospital/Practice (3)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Clinical study phase I